III Catalan registry of ST elevation acute myocardial infarction. Comparison with former Catalan registries I and II from Catalonia, Spain;Resultados del III registro IAM CAT de pacientes con infarto de miocardio con elevación del segmento ST en Cataluña. Comparación con los registros IAM CAT I y II

Medicina Clinica

Volumn 133, Issue 18, 2009, Pages 694-701

  Figueras, Jaume ^a   Heras, Magda ^a   Baigorri, Francisco ^a   Elosua, Roberto ^a   Ferreira, Ignacio ^a   Santaló, Miquel ^a  

^a Societat Catalana de Cirurgia   (Spain)

Author keywords

Catalonia; IAM CAT; Myocardial infarction; Myocardial reperfusion; Registry

Indexed keywords

ACUTE HEART INFARCTION; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; HOSPITALIZATION; HUMAN; MORTALITY; SCANNING ELECTROCHEMICAL MICROSCOPY; SPAIN; ST SEGMENT ELEVATION;

AGED; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; REGISTRIES; SPAIN;

EID: 70350778459     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.07.017     Document Type: Article

References (25)

1. Gruppo italiano per lo studio della Streptochinasi nell' infarcto miocardico (GISS). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1 (1986) 397-401
2. The GUSTO angiographic investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329 (1993) 1615-1622
3. White H.D., Cross D.B., Elliott J.M., Norris R.M., and Lee T.W. Long-term prognostic importance of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation 89 (1994) 61-67
4. Fibrinolytic Therapy Trialist (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all ramdomised trials of more than 1000 patients. Lancet 343 (1994) 311-322
5. Grines C.L., Browne K.F., Marco J., Rothbaum D., Stone G.M., O'Keefe J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 328 (1993) 673-679
6. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 44 (2004) 671-719
7. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
8. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., Jacobs A.K., Kern M.J., King S.B., et al. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention). J Am Coll Cardiol 47 (2006) 216-235
9. Pinto D.S., Kirtane A.J., Nallamothu B.K., Murphy S.A., Cohen D.J., Laham R.J., et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: Implications when selecting a reperfusion strategy. Circulation 114 (2006) 2019-2025
10. Boersma E., and The Primary Coronary Angioplasty vs. Thrombolysis Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 27 (2006) 779-788
11. Armstrong P.W., and WEST Steering Committee. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: The WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J 27 (2006) 1530-1538
12. Figueras J., Masip J., Bruguera J., Curós A., Baigorri F., Santaló M., et al. Resultats del registre de l'infart de miocardi amb elevació del segment ST a Catalunya. Rev Soc Catalana Cardiol 4 (2002) 206-214
13. Figueras J., Masip J., Bruguera J., Curós A., Baigorri F., Santaló M., et al. Resultats del II registre de l'infart agut de miocardi amb elevació del segment ST a Catalunya. Rev Soc Catalana Cardiol 5 (2005) 298-310
14. Arós F., Cuñat J., Loma-Osorio A., Torrado E., Bosch X., Rodriguez J.J., et al. Tratamiento del infarto agudo de miocardio en España en el año 2000. El estudio PRIAMHO II. Rev Esp Cardiol 56 (2003) 1165-1173
15. Rogers W.J., Canto J.G., Lambrew C.T., Tiefenbrunn A.J., Kinkaid B., Shoultz D.A., et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: The National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 36 (2000) 2056-2063
16. Eagle K.A., Goodman S.G., Avezum A., Budaj A., Sullivan C.M., and Lopez Sendón J. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: Findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 359 (2002) 373-377
17. Hasdai D., Behar S., Wallentin L., Danchin N., Gitt A.K., Boersma E., et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Meditarrenean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 23 (2002) 1190-1201
18. Aguayo de Hoyos E., Reina A., Colmenero M., Barranco M., Pola M., Jimenez M., and Grupo ARIAM. Análisis de los retrasos en el tratamiento del síndrome coronario agudo. Datos de registro ARIAM. Med Intensiva 23 (1999) 280-287
19. Cabadés A., Marrugat J., Lopez-Bescós L., Pereferrer D., De los Reyes M., Sanjosé J.M., and en nombre de los investigadores del estudio "Proyecto de Registro de Infarto Agudo de Miocardio Hospitalario" (PRIAMHO). Bases para un registro hospitalario de infartos agudos de miocardio en España. El estudio PRIAMHO. Rev Esp Cardiol 34 (1996) 334-344
20. Arós F., Loma-Osorio A., Bosch X., Gonzalez-Aracil J., Lopez-Becós L., Marrugat J., et al., en nombre de los investigadores del registro RISCI. Manejo del infarto de miocardio en España (1995-99). Datos del registro de infartos de la Sección de Cardiopatia Isquémica y Unidades Coronarias (RISCI). Rev Esp Cardiol 54 (2001) 1033-1040
21. Heras M., Marrugat J., Arós F., Bosch X., Enero J., and Suárez M.A.y.col. Reducción de la mortalidad por infarto agudo de miocardio en un período de 5 años. Rev Esp Cardiol 59 (2006) 200-208
22. De Winter R.J., Windhausen F., Cornel J.H., Dunselman P.H., Janus C.L., Bendermacher P.E., et al. Early invasive versus selective invasive management for acute coronary syndromes. N Engl J Med 353 (2005) 1095-1104
23. Mehta S.R., Cannon C.P., Fox K.A.A., Wallentin L., Boden W.E., Spacek R., et al. Routine vs selective invasive strategies in patients with acute coronary syndromes. A collaborative meta-analysis of randomized trials. JAMA 293 (2005) 2908-2917
24. Ryan J.W., Peterson E.D., Chen A.Y., Roe M.T., Ohman E.M., Cannon C.P., et al. Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes. Insights from the CRUSADE (Can rapid risk stratification of Unstable Angina patients Suppress Adverse outcomes with Early implementation of the ACCC/AHA guidelines) registry. Circulation 112 (2005) 3049-3057
25. Bueno H., Bardaji A., Fernandez Ortiz A., Marrugat J., Martí H., Heras M.y.col., et al. Manejo del síndrome coronario agudo sin elevación del segmento ST en España. Estudio DESCARTES (Descripción del Estado de los Síndromes Coronarios Agudos en un Registro Temporal Español). Rev Esp Cardiol 58 (2005) 244-252